Smedvig logo

Smedvig

Europe, Rogaland, Norway, Stavanger

Description

The history of the Smedvig family’s operations demonstrates an excellent track record in managing businesses.

Investor Profile

Smedvig has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Undisclosed rounds (top funding stages).
  • Majority of deals are located in Belgium, South Africa.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series A (50%)
  • Undisclosed (50%)

Country Focus

  • Belgium (50%)
  • South Africa (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Mining
  • Precious Metals
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Smedvig frequently co-invest with?

6V
Europe, Hainaut, Belgium, Charleroi
Co-Investments: 1
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 1
Co-Investments: 1
Mérieux Equity Partners
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1

Which angels does Smedvig often collaborate with?

KB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Smedvig?

DRUID AI

Bucharest, Bucuresti, Romania

DRUID AI is an enterprise AI platform that builds and deploys AI agents and intelligent applications that automate business workflows.

Artificial Intelligence (AI)Enterprise SoftwareInformation TechnologyMachine LearningSoftwareVirtual Workforce
Series CSep 16, 2025
Amount Raised: $31,000,000
Sedibelo Resources

Centurion, NA - South Africa, South Africa

Sedibelo Resources is a developing producer of platinum group metals (PGMs), is active in the acquisition, exploration.

MiningPrecious Metals
UndisclosedMar 7, 2025
Amount Raised: $3,000,000
Amyl Therapeutics

Liège, Liege, Belgium

Amyl Therapeutics is a preclinical stage biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
Series AJun 3, 2021
Amount Raised: $10,432,525